Correlation Between Bristol Myers and Fast Retailing

Can any of the company-specific risk be diversified away by investing in both Bristol Myers and Fast Retailing at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bristol Myers and Fast Retailing into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Bristol Myers Squibb and Fast Retailing Co, you can compare the effects of market volatilities on Bristol Myers and Fast Retailing and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bristol Myers with a short position of Fast Retailing. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bristol Myers and Fast Retailing.

Diversification Opportunities for Bristol Myers and Fast Retailing

0.09

Correlation Coefficient

Bristol Myers  Fast Retailing

Significant diversification

The 3 months correlation between Bristol and Fast is 0.09. Overlapping area represents the amount of risk that can be diversified away by holding Bristol Myers Squibb and Fast Retailing Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fast Retailing and Bristol Myers is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bristol Myers Squibb are associated (or correlated) with Fast Retailing. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fast Retailing has no effect on the direction of Bristol Myers i.e., Bristol Myers and Fast Retailing go up and down completely randomly.

Pair Corralation between Bristol Myers and Fast Retailing

Considering the 90-day investment horizon Bristol Myers Squibb is expected to under-perform the Fast Retailing. But the stock apears to be less risky and, when comparing its historical volatility, Bristol Myers Squibb is 7.24 times less risky than Fast Retailing. The stock trades about -0.01 of its potential returns per unit of risk. The Fast Retailing Co is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  19,143  in Fast Retailing Co on September 24, 2024 and sell it today you would earn a total of  14,117  from holding Fast Retailing Co or generate 73.74% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	75.9%
Values	Daily Returns

Bristol Myers Squibb  vs.  Fast Retailing Co

Bristol Myers Squibb

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Bristol Myers Squibb are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady primary indicators, Bristol Myers showed solid returns over the last few months and may actually be approaching a breakup point.

Fast Retailing

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Fast Retailing Co are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Fast Retailing may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with Bristol Myers and Fast Retailing

The main advantage of trading using opposite Bristol Myers and Fast Retailing positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bristol Myers position performs unexpectedly, Fast Retailing can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fast Retailing will offset losses from the drop in Fast Retailing's long position.

The idea behind Bristol Myers Squibb and Fast Retailing Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.